Viboud Cecile, Miller Mark, Olson Don, Osterholm Michael, Simonsen Lone
Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.
PLoS Curr. 2010 Mar 20;2:RRN1153. doi: 10.1371/currents.rrn1153.
The on-going debate about the health burden of the 2009 influenza pandemic and discussions about the usefulness of vaccine recommendations has been hampered by an absence of directly comparable measures of mortality impact. Here we set out to generate an "apples-to-apples" metric to compare pandemic and epidemic mortality. We estimated the mortality burden of the pandemic in the US using a methodology similar to that used to generate excess mortality burden for inter-pandemic influenza seasons. We also took into account the particularly young age distribution of deaths in the 2009 H1N1 pandemic, using the metric "Years of Life Lost" instead of numbers of deaths. Estimates are based on the timely pneumonia and influenza mortality surveillance data from 122 US cities, and the age distribution of laboratory-confirmed pandemic deaths, which has a mean of 37 years. We estimated that between 7,500 and 44,100 deaths are attributable to the A/H1N1 pandemic virus in the US during May-December 2009, and that between 334,000 and 1,973,000 years of life were lost. The range of years of life lost estimates includes in its lower part the impact of a typical influenza epidemic dominated by the more virulent A/H3N2 subtype, and the impact of the 1968 pandemic in its upper bound. We conclude that the 2009 A/H1N1 pandemic virus had a substantial health burden in the US over the first few months of circulation in terms of years of life lost, justifying the efforts to protect the population with vaccination programs. Analysis of historic records from three other pandemics over the last century suggests that the emerging pandemic virus will continue to circulate and cause excess mortality in unusually young populations for the next few years. Continuing surveillance for indicators of increased mortality is of key importance, as pandemics do not always cause the majority of associated deaths in the first season of circulation.
关于2009年流感大流行的健康负担的持续争论以及关于疫苗接种建议的实用性的讨论,因缺乏直接可比的死亡率影响衡量标准而受到阻碍。在此,我们着手制定一个“同类相比”的指标,以比较大流行和流行期间的死亡率。我们使用了一种类似于用于计算大流行间期流感季节超额死亡负担的方法,来估计美国大流行的死亡负担。我们还考虑到2009年甲型H1N1流感大流行中死亡人群的年龄分布特别年轻,使用了“寿命损失年数”这一指标而非死亡人数。估计值基于来自美国122个城市的及时的肺炎和流感死亡率监测数据,以及实验室确诊的大流行死亡病例的年龄分布,其平均年龄为37岁。我们估计,在2009年5月至12月期间,美国有7500至44100例死亡可归因于甲型H1N1流感大流行病毒,并且损失了334000至1973000个寿命年。寿命损失年数估计值的范围,下限包括以毒性更强的甲型H3N2亚型为主导的典型流感流行的影响,上限包括1968年大流行的影响。我们得出结论,就寿命损失年数而言,2009年甲型H1N1流感大流行病毒在美国传播的最初几个月造成了巨大的健康负担,这证明了通过疫苗接种计划保护人群的努力是合理的。对上世纪另外三次大流行的历史记录分析表明,新出现的大流行病毒在未来几年将继续传播,并在异常年轻的人群中导致超额死亡。持续监测死亡率上升的指标至关重要,因为大流行并不总是在传播的第一个季节导致大多数相关死亡。